E
REGENXBIO Inc. RGNX
$6.72 $0.172.60%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -12.33% 8.53%
Total Other Revenue -- --
Total Revenue -12.33% 8.53%
Cost of Revenue -327.23% 337.33%
Gross Profit 506.01% -707.37%
SG&A Expenses -22.51% 3.01%
Depreciation & Amortization -- --
Other Operating Expenses 2,151.35% 27.59%
Total Operating Expenses -15.87% 10.14%
Operating Income 17.25% -10.78%
Income Before Tax 14.11% -12.47%
Income Tax Expenses -- --
Earnings from Continuing Operations 14.11% -12.47%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 14.11% -12.47%
EBIT 17.25% -10.78%
EBITDA 18.54% -11.79%
EPS Basic 14.23% -12.03%
Normalized Basic EPS 14.23% -12.02%
EPS Diluted 14.23% -11.73%
Normalized Diluted EPS 14.23% -12.02%
Average Basic Shares Outstanding 0.14% 0.39%
Average Diluted Shares Outstanding 0.14% 0.39%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings